Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: Implications for the Research Domain Criteria (RDoC)

Journal of Affective Disorders

Volumn 163, Issue , 2014, Pages 18-24

  Østergaard, Søren D ^a,b,c   Bech, Per ^d   Trivedi, Madhukar H ^e   Wisniewski, Stephen R ^f   Rush, A John ^g   Fava, Maurizio ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Aalborg Psykiatriske Sygehus   (Denmark)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Mental Health Services CPH   (Denmark)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Depression; Psychometrics; Research Domain Criteria

Indexed keywords

CITALOPRAM;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISABILITY SEVERITY; DISEASE COURSE; DRUG EFFECT; HAMILTON SCALE; HUMAN; INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY; MAJOR CLINICAL STUDY; MELANCHOLIA; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; QUALITY OF LIFE; QUALITY OF LIFE ENJOYMENT AND SATISFACTION QUESTIONNAIRE; TREATMENT RESPONSE;

DEPRESSION; PSYCHOMETRICS; RESEARCH DOMAIN CRITERIA;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; HUMANS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84898776745     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.03.049     Document Type: Article

References (50)

1. American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. Washington, DC.
2. R.M. Bagby, A.G. Ryder, D.R. Schuller, and M.B. Marshall The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am. J. Psychiatry 161 2004 2163 2177 (Pubitemid 39587278)
3. P. Bech, L.F. Gram, E. Dein, O. Jacobsen, J. Vitger, and T.G. Bolwig Quantitative rating of depressive states Acta Psychiatr. Scand. 51 1975 161 170
4. P. Bech, P. Allerup, L.F. Gram, N. Reisby, R. Rosenberg, O. Jacobsen, and A. Nagy The Hamilton depression scale. Evaluation of objectivity using logistic models Acta Psychiatr. Scand. 63 1981 290 299 (Pubitemid 11137960)
5. P. Bech, P. Allerup, N. Reisby, and L.F. Gram Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants Psychopharmacology (Berl) 84 1984 276 281 (Pubitemid 14006586)
6. P. Bech, K.B. Stage, N.P. Nair, J.K. Larsen, P. Kragh-Sorensen, and A. Gjerris The Major Depression Rating Scale (MDS). Inter-rater reliability and validity across different settings in randomized moclobemide trials. Danish University Antidepressant Group J. Affect. Disord. 42 1997 39 48 (Pubitemid 27145470)
7. P. Bech Pharmacological treatment of depressive disorders:a review M. Maj, N. Sartorius, Depressive Disorders. WPA Series Evidence and Experience in Psychiatry 1999 John Wiley & Sons Chichester 89 127
8. P. Bech, P. Cialdella, M.C. Haugh, M.A. Birkett, A. Hours, J.P. Boissel, and G.D. Tollefson Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression Br. J. Psychiatry 176 2000 421 428 (Pubitemid 30249617)
9. P. Bech Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression Int. J. Neuropsychopharmacol. 4 2001 337 345 (Pubitemid 33151677)
10. P. Bech, P. Tanghoj, H.F. Andersen, and K. Overo Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression Psychopharmacology (Berl) 163 2002 20 25 (Pubitemid 34985308)
11. P. Bech, H.F. Andersen, and A. Wade Effective dose of escitalopram in moderate versus severe DSM-IV major depression Pharmacopsychiatry 39 2006 128 134 (Pubitemid 44199180)
12. P. Bech, D.K. Kajdasz, and V. Porsdal Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder Psychopharmacology (Berl) 188 2006 273 280 (Pubitemid 44387455)
13. P. Bech Applied psychometrics in clinical psychiatry: the pharmacopsychometric triangle Acta Psychiatr. Scand. 120 2009 400 409
14. P. Bech Is the antidepressive effect of second-generation antidepressants a myth? Psychol. Med. 40 2010 181 186
15. P. Bech, P. Boyer, J.M. Germain, K. Padmanabhan, V. Haudiquet, B. Pitrosky, and K.A. Tourian HAM-D17 and HAM-D6 sensitivity to change in relation to desvenlafaxine dose and baseline depression severity in major depressive disorder Pharmacopsychiatry 43 2010 271 276
16. P. Bech, M. Fava, M.H. Trivedi, S.R. Wisniewski, and A.J. Rush Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets J. Affect. Disord. 132 2011 396 400
17. P. Bech Clinical Psychometrics 2012 Wiley-Blackwell Oxford, UK
18. P. Bech, P. Allerup, E.R. Larsen, C. Csillag, and R.W. Licht Escitalopram versus nortriptyline: how to let the clinical GENDEP data tell us what they contained Acta Psychiatr. Scand. 127 2013 328 329
19. P. Bech, J. Bille, S.B. Moller, L.C. Hellstrom, and S.D. Ostergaard Psychometric validation of the Hopkins Symptom Checklist (SCL-90) subscales for depression, anxiety, and interpersonal sensitivity J. Affect. Disord. 2013
20. J. Bent-Hansen, and P. Bech Validity of the definite and semidefinite questionnaire version of the Hamilton Depression Scale, the Hamilton Subscale and the Melancholia Scale. Part I Eur. Arch. Psychiatry Clin. Neurosci. 261 2011 37 46
21. T.J. Carmody, A.J. Rush, I. Bernstein, D. Warden, S. Brannan, D. Burnham, A. Woo, and M.H. Trivedi The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures Eur. Neuropsychopharmacol. 16 2006 601 611 (Pubitemid 44716667)
22. B.N. Cuthbert, and T.R. Insel Toward the future of psychiatric diagnosis: the seven pillars of RDoC BMC Med. 11 2013 126
23. B.N. Cuthbert, and M.J. Kozak Constructing constructs for psychopathology: the NIMH research domain criteria J. Abnorm. Psychol. 122 2013 928 937
24. S. Embretson L.M. Collins, J.L. Horn, Best Methods for the Analysis of Change. 1991 American Psychological Association Washington DC 184 187
25. J. Endicott, J. Nee, W. Harrison, and R. Blumenthal Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure Psychopharmacol. Bull. 29 1993 321 326 (Pubitemid 23311543)
26. E.I. Fried, R.M. Nesse, K. Zivin, C. Guille, and S. Sen Depression is more than the sum score of its parts: individual DSM symptoms have different risk factors Psychol. Med. 2013 1 10
27. M. Hamilton Development of a rating scale for primary depressive illness Br. J. Soc. Clin. Psychol. 6 1967 278 296
28. P.E. Holtzheimer, and H.S. Mayberg Stuck in a rut: rethinking depression and its treatment Trends Neurosci. 34 2011 1 9
29. T. Insel, B. Cuthbert, M. Garvey, R. Heinssen, D.S. Pine, K. Quinn, C. Sanislow, and P. Wang Research domain criteria (RDoC): toward a new classification framework for research on mental disorders Am. J. Psychiatry 167 2010 748 751
30. R.W. Licht, S. Qvitzau, P. Allerup, and P. Bech Validation of the Bech-Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression; is the total score a valid measure of illness severity? Acta Psychiatr. Scand. 111 2005 144 149 (Pubitemid 40293182)
31. L.L. Magnusson Hanson, H. Westerlund, C. Leineweber, R. Rugulies, W. Osika, T. Theorell, and P. Bech The Symptom Checklist-core depression (SCL-CD6) scale: psychometric properties of a brief six item scale for the assessment of depression Scand. J. Public Health 42 2014 82 88
32. Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium S. Ripke, N.R. Wray, C.M. Lewis, S.P. Hamilton, M.M. Weissman, G. Breen, E.M. Byrne, D.H. Blackwood, D.I. Boomsma, S. Cichon, A.C. Heath, F. Holsboer, S. Lucae, P.A. Madden, N.G. Martin, P. McGuffin, P. Muglia, M.M. Noethen, B.P. Penninx, M.L. Pergadia, J.B. Potash, M. Rietschel, D. Lin, B. Muller-Myhsok, J. Shi, S. Steinberg, H.J. Grabe, P. Lichtenstein, P. Magnusson, R.H. Perlis, M. Preisig, J.W. Smoller, K. Stefansson, R. Uher, Z. Kutalik, K.E. Tansey, A. Teumer, A. Viktorin, M.R. Barnes, T. Bettecken, E.B. Binder, R. Breuer, V.M. Castro, S.E. Churchill, W.H. Coryell, N. Craddock, I.W. Craig, D. Czamara, E.J. De Geus, F. Degenhardt, A.E. Farmer, M. Fava, J. Frank, V.S. Gainer, P.J. Gallagher, S.D. Gordon, S. Goryachev, M. Gross, M. Guipponi, A.K. Henders, S. Herms, I.B. Hickie, S. Hoefels, W. Hoogendijk, J.J. Hottenga, D.V. Iosifescu, M. Ising, I. Jones, L. Jones, T. Jung-Ying, J.A. Knowles, I.S. Kohane, M.A. Kohli, A. Korszun, M. Landen, W.B. Lawson, G. Lewis, D. Macintyre, W. Maier, M. Mattheisen, P.J. McGrath, A. McIntosh, A. McLean, C.M. Middeldorp, L. Middleton, G.M. Montgomery, S.N. Murphy, M. Nauck, W.A. Nolen, D.R. Nyholt, M. O'Donovan, H. Oskarsson, N. Pedersen, W.A. Scheftner, A. Schulz, T.G. Schulze, S.I. Shyn, E. Sigurdsson, S.L. Slager, J.H. Smit, H. Stefansson, M. Steffens, T. Thorgeirsson, F. Tozzi, J. Treutlein, M. Uhr, E.J. van den Oord, G. Van Grootheest, H. Volzke, J.B. Weilburg, G. Willemsen, F.G. Zitman, B. Neale, M. Daly, D.F. Levinson, and P.F. Sullivan A mega-analysis of genome-wide association studies for major depressive disorder Mol. Psychiatry 18 2013 497 511
33. P.J. McGrath, A.Y. Khan, M.H. Trivedi, J.W. Stewart, D.W. Morris, S.R. Wisniewski, S. Miyahara, A.A. Nierenberg, M. Fava, and A.J. Rush Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report J. Clin. Psychiatry 69 2008 1847 1855
34. H.J. Moller Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale Eur. Arch. Psychiatry Clin. Neurosci. 251 Suppl. 2:II 2001 S13 S20
35. National Institute of Mental Health, 2011. NIMH Research Domain Criteria (RDoC) matrix: http://www.nimh.nih.gov/research-priorities/rdoc/nimh-research- domain-criteria-rdoc.shtml#toc-matrix (accessed 14.11.13).
36. S.D. Ostergaard, S.O. Jensen, and P. Bech The heterogeneity of the depressive syndrome: when numbers get serious Acta Psychiatr. Scand. 124 2011 495 496
37. S.D. Ostergaard, B.S. Meyers, A.J. Flint, B.H. Mulsant, E.M. Whyte, C.M. Ulbricht, P. Bech, A.J. Rothschild STOP-PD Study Group Measuring psychotic depression Acta Psychiatr. Scand. 129 2014 211 220
38. S.D. Ostergaard, B.S. Meyers, A.J. Flint, B.H. Mulsant, E.M. Whyte, C.M. Ulbricht, P. Bech, A.J. Rothschild STOP-PD Study Group Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account J. Affect. Disord. 2014 (Published online ahead of print) http://dx.doi.org/10.1016/j.jad. 2013.12.020
39. G. Parker Major running on the spot World Psychiatry 9 2010 165 166
40. A.J. Rush, D.E. Giles, M.A. Schlesser, C.L. Fulton, J. Weissenburger, and C. Burns The Inventory for Depressive Symptomatology (IDS): preliminary findings Psychiatry Res. 18 1986 65 87 (Pubitemid 16085767)
41. A.J. Rush, M. Fava, S.R. Wisniewski, P.W. Lavori, M.H. Trivedi, H.A. Sackeim, M.E. Thase, A.A. Nierenberg, F.M. Quitkin, T.M. Kashner, D.J. Kupfer, J.F. Rosenbaum, J. Alpert, J.W. Stewart, P.J. McGrath, M.M. Biggs, K. Shores-Wilson, B.D. Lebowitz, L. Ritz, G. Niederehe STAR*D Investigators Group Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design Control. Clin. Trials 25 2004 119 142 (Pubitemid 38230109)
42. A.J. Rush, T.J. Carmody, H.M. Ibrahim, M.H. Trivedi, M.M. Biggs, K. Shores-Wilson, M.L. Crismon, M.G. Toprac, and T.M. Kashner Comparison of self-report and clinician ratings on two inventories of depressive symptomatology Psychiatr. Serv. 57 2006 829 837 (Pubitemid 43846295)
43. P. Sullivan 96 Psychiatric Genetics Investigators Don't give up on GWAS Mol. Psychiatry 17 2012 2 3
44. S.C. Sung, S.R. Wisniewski, G.K. Balasubramani, S. Zisook, B. Kurian, D. Warden, M.H. Trivedi, A.J. Rush CO-MED Study Team Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report Psychol. Med. 43 2013 945 960
45. S.D. Targum, M.H. Pollack, and M. Fava Redefining affective disorders: relevance for drug development CNS Neurosci. Ther. 14 2008 2 9
46. M.E. Thase, C.L. Bowden, M. Nashat, J.M. Eudicone, R. Marcus, R.D. McQuade, and B.X. Carlson Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms Int. J. Psychiatry Clin. Pract. 16 2012 121 131
47. M.H. Trivedi, A.J. Rush, S.R. Wisniewski, A.A. Nierenberg, D. Warden, L. Ritz, G. Norquist, R.H. Howland, B. Lebowitz, P.J. McGrath, K. Shores-Wilson, M.M. Biggs, G.K. Balasubramani, M. Fava STAR*D Study Team Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice Am. J. Psychiatry 163 2006 28 40 (Pubitemid 43050100)
48. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research 1993 WHO Geneva
49. M. Zimmerman, J.H. Martinez, D. Young, I. Chelminski, and K. Dalrymple Severity classification on the Hamilton Depression Rating Scale J. Affect. Disord. 150 2013 384 388
50. S. Zisook, M.H. Trivedi, D. Warden, B. Lebowitz, M.E. Thase, J.W. Stewart, C. Moutier, M. Fava, S.R. Wisniewski, J. Luther, and A.J. Rush Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study J. Affect. Disord. 117 2009 63 73